Position in OMER
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$1,085,758
-$634,045 QoQ
Shares Held
102,818
+2.7% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 37.21235581318446.ToString("F0")%
Shared 0.ToString("F0")%
None 62.78764418681554.ToString("F0")%
Common Shares in OMER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. OMER ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in OMER
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,085,758 | 102,818 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,719,803 | 100,105 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $434,079 | 105,873 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $296,475 | 98,825 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $884,447 | 107,597 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $1,069,243 | 108,223 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $427,406 | 107,659 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $453,818 | 111,778 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $363,433 | 105,343 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $356,701 | 109,083 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $263,351 | 90,189 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $496,345 | 91,240 | Shares | Sole | 2023-08-08 | |
| 2022-03-31 | $433,639 | 72,153 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $457,783 | 71,195 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $997,789 | 72,356 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,110,714 | 74,846 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,232,062 | 69,217 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $1,083,124 | 75,796 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $703,221 | 69,557 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,208,909 | 82,127 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $946,061 | 70,760 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||